<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Saudi J Gastroenterol</journal-id><journal-id journal-id-type="iso-abbrev">Saudi J Gastroenterol</journal-id><journal-id journal-id-type="publisher-id">SJG</journal-id><journal-title-group><journal-title>Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association</journal-title></journal-title-group><issn pub-type="ppub">1319-3767</issn><issn pub-type="epub">1998-4049</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">22824768</article-id><article-id pub-id-type="pmc">3409886</article-id><article-id pub-id-type="publisher-id">SJG-18-252</article-id><article-id pub-id-type="doi">10.4103/1319-3767.98430</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Increased Protein Carbonylation and Decreased Antioxidant Status in Anemic <italic>H. Pylori</italic> Infected Patients: Effect of Treatment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rajendiran</surname><given-names>Soundravally</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Zachariah</surname><given-names>Bobby</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Hamide</surname><given-names>Abdoul</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib></contrib-group><aff id="aff1">Department of Biochemistry, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India</aff><aff id="aff2"><label>1</label>Department of Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Bobby Zachariah, Department of Biochemistry, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry - 605 006, India. E-mail: <email xlink:href="zacbobby@yahoo.com">zacbobby@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jul-Aug</season><year>2012</year></pub-date><volume>18</volume><issue>4</issue><fpage>252</fpage><lpage>256</lpage><history><date date-type="received"><day>03</day><month>10</month><year>2011</year></date><date date-type="accepted"><day>19</day><month>2</month><year>2012</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; Saudi Journal of Gastroenterology</copyright-statement><copyright-year>2012</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Background/Aim:</title><p>Collective evidences suggest the causal association of <italic>Helicobacter pylori</italic> infection with iron deficiency anemia. Generation of free radicals against this bacterium can lead to turbulence in oxidative-antioxidative system. This study was undertaken to evaluate the marker of oxidative protein injury, protein carbonylation, and total antioxidant status in anemic <italic>H. pylori</italic>-infected patients and to observe the alteration in them after treatment for 1 month with oral ferrous sulfate and anti-<italic>H. pylori</italic> therapy. Twenty anemic <italic>H. pylori</italic>-infected patients were randomly divided into 2 groups. The <italic>H. pylori</italic>-infected patients in Group I received both iron supplementation and anti-H pylori therapy, whereas patients in Group II received only the iron supplementation. Fifteen healthy volunteers served as controls. All the study parameters were estimated after 1 month of the treatment.</p></sec><sec id="st2"><title>Materials and Methods:</title><p>Protein carbonylation and total antioxidant status were estimated using colorimetric method. Hematologic parameters were evaluated using Sysmex-K-100 automated cell counter.</p></sec><sec id="st3"><title>Results:</title><p>In anemic <italic>H. pylori</italic>-infected patients, the protein carbonyls (PCOs) were significantly increased, whereas the total antioxidant status, iron, hemoglobin, and ferritin levels were significantly decreased compared with the controls. In Group I, while the PCOs level decreased significantly, there was a significant increase in the total antioxidant status, iron, hemoglobin, and ferritin levels after 1 month. No significant alterations were noted in the levels of PCOs, total antioxidant status, iron, hemoglobin, or ferritin in Group II patients after 1 month of the treatment.</p></sec><sec id="st4"><title>Conclusions:</title><p>The findings from this study indicate that treatment for both anemia and <italic>H. pylori</italic> infections is required for lowering the oxidative stress markers, which synergistically bring about an appropriate correction of anemia soon in these patients.</p></sec></abstract><kwd-group><kwd><italic>H. pylori</italic></kwd><kwd>iron deficiency anemia</kwd><kwd>protein carbonyls</kwd><kwd>total antioxidant status</kwd></kwd-group></article-meta></front><body><p><italic>Helicobacter pylori</italic>, a gram-negative bacillus, is the most common pathogenic bacteria in the world.[<xref ref-type="bibr" rid="ref1">1</xref>] Approximately half of the population worldwide has <italic>H. pylori</italic> infection, and the prevalence is expected to be 80-90% in the developing countries and 30&#x02013;50% in the developed countries.[<xref ref-type="bibr" rid="ref2">2</xref>]</p><p>Earlier studies suggest an association between <italic>H. pylori</italic>-induced gastritis and iron deficiency anemia.[<xref ref-type="bibr" rid="ref3">3</xref>&#x02013;<xref ref-type="bibr" rid="ref6">6</xref>] Epidemiologic studies have shown that persons seropositive for <italic>H. pylori</italic> infections have a significant lower serum ferritin level.[<xref ref-type="bibr" rid="ref3">3</xref><xref ref-type="bibr" rid="ref4">4</xref>] It has also been found that eradication of <italic>H. pylori</italic> infection in iron-deficient anemic patients was found to reverse the iron deficiency status in both children and adults.[<xref ref-type="bibr" rid="ref5">5</xref><xref ref-type="bibr" rid="ref6">6</xref>]</p><p><italic>H. pylori</italic> infection increases free radical generation.[<xref ref-type="bibr" rid="ref7">7</xref>] <italic>H. pylori</italic>-induced gastritis is an established risk factor for gastric cancer.[<xref ref-type="bibr" rid="ref1">1</xref>] One of the mechanisms that predisposes to cancer is the generation of free radicals due to inflammatory response against the bacterium. The generated free radicals bring about carcinogenesis by direct effect on host DNA and also by promoting the production of genotoxic products, such as Malondialdehyde (MDA).[<xref ref-type="bibr" rid="ref8">8</xref><xref ref-type="bibr" rid="ref9">9</xref>] Several studies are available that suggest the altered oxidative stress and antioxidant enzyme activities in <italic>H. pylori</italic>-induced gastritis and gastric cancer.[<xref ref-type="bibr" rid="ref10">10</xref>&#x02013;<xref ref-type="bibr" rid="ref12">12</xref>] Even in iron deficiency anemia, an increased level of MDA was observed and iron treatment significantly reduced it.[<xref ref-type="bibr" rid="ref13">13</xref><xref ref-type="bibr" rid="ref14">14</xref>]</p><p>Evidence for oxidative injury is obtained predominantly from the measurement of biochemical markers of lipid peroxidation and protein oxidation. MDA and protein carbonyls (PCOs) are byproducts of oxidation of lipids and proteins, respectively.[<xref ref-type="bibr" rid="ref10">10</xref>] Oxidized proteins are generally more stable; hence PCOs have a major advantage over lipid peroxidation products as markers of oxidative stress. Moreover, PCOs are formed early and circulate in blood for longer periods, compared with other parameters of oxidative stress, such as glutathione disulfide and MDA.[<xref ref-type="bibr" rid="ref15">15</xref>] The formation of PCOs is a common phenomenon during oxidation, and their quantification can be used to measure the extent of oxidative modification.</p><p>Although separate reports are available suggesting altered oxidative stress in <italic>H. pylori</italic> infection and iron deficiency anemia, to the best of our knowledge, the levels of protein carbonylation and antioxidant status in anemic <italic>H. pylori</italic> infection and the effects of treatment still remain unexplored.</p><p>Therefore, the major aims of this study were (a) to compare the levels of PCOs and total antioxidant status in anemic <italic>H. pylori</italic>-infected individuals with normal age-matched controls and, (b) to determine the effect of treatment on the levels of these parameters.</p><sec sec-type="materials|methods" id="sec1-1"><title>MATERIALS AND METHODS</title><p>Three milliliters of blood samples were obtained from 20 anemic patients with <italic>H. pylori</italic> infection (12 females and 8 males) and 16 age-matched apparently healthy subjects. Anemic patients were recruited from the outpatient department of our institute, JIPMER, Puducherry, India. Only 13 years or older patients were enrolled for this study. The patients were aged between 30 and 49 years. Anemic patients were selected based on the hemoglobin levels (Hb &#x0003c; 11 g/dL) and peripheral blood smear suggesting iron deficiency anemia. One milliliter of the whole blood in EDTA vials was collected and used for the analysis of hemoglobin and red cell indices using Sysmex-K-100 automated cell counter (Sysmex Singapore Pvt. Ltd, Singapore). The rest of the sample was centrifuged at 3000g for 10 min and stored at &#x02212;20&#x000b0;C until use. Plasma ferritin level was determined by ELISA using human ferritin enzyme immunoassay test kit (IBL Immunobiological Laboratories, Hamburg, Germany). Plasma iron was measured by fully automated ferrozine method in Ciba Corning 550 Express Plus. All patients who were found to have iron deficiency by the above parameters underwent stool examination on 3 consecutive days for the presence of hookworm ova on microscopy and for occult blood by benzidine test. After informed consent, upper gastrointestinal endoscopy was done and multiple biopsy specimens were obtained from the antral mucosa for rapid urease test and histology. Tissue sections were stained for <italic>H. pylori</italic> with Geimsa. <italic>H. pylori</italic> infection was defined as a visible organism seen under microscopy and a positive rapid urease test. Among the 20 <italic>H. pylori</italic> patients, 7 had antral gastritis, 5 had atrophic gastritis, and 2 had pangastritis; in the remaining 6 patients, endoscopy revealed normal mucosa. Patients with a history of consumption of nonsteroidal anti-inflammatory drugs (NSAIDs), anticoagulants, or corticosteroids; those with hematologic disorders or stool samples positive for occult blood or hookworm ova; those diagnosed with duodenal or gastric ulcers or carcinoma stomach at endoscopy were excluded from the study. Those positive for <italic>H. pylori</italic> infection detected by rapid urease test and histology were randomly placed into 2 groups (groups I and II) by creating block sizes of 6 or 8 and linking to 5-digit random numbers (Rand Corporation; New York: The Free Press, 1955). Patients in Group I received oral ferrous sulfate tablets 200 mg thrice daily for 1 month, and a 14-day course of anti-<italic>H. pylori</italic> therapy consisting of clarithromycin 250 mg BD, lansoprazole 30 mg BD, and tinidazole 500 mg BD. Those in Group II received only oral ferrous sulfate tablets as mentioned above. All the above-mentioned biochemical and hematologic parameters were assayed before and after 1 month of therapy. The <italic>H. pylori</italic> infection in the control group was excluded by the rapid urease test. Patients with this study were approved by the Human Ethics Committee and Institute Research Committee of JIPMER. Informed consent was obtained from all subjects.</p><sec id="sec2-1"><title>Assay of carbonylation of plasma protein</title><p>The assay was done according to the method of Levine <italic>et al</italic>.[<xref ref-type="bibr" rid="ref16">16</xref>] The millimolar extinction coefficient of the colored product is 22.01 mmol<sup>&#x02212;1</sup> cm<sup>&#x02212;1</sup> at 366 nm. The carbonylated protein reacts with 2,4-dinitrophenyhydrazine to form a colored adduct of 2,4-dinitrophenylhydrazone. Plasma total protein was estimated by biuret method using fully automated autoanalyzer 550 express plus (Bayers Diagnostics Ciba, Corning, NY, USA).</p></sec><sec id="sec2-2"><title>Total plasma antioxidant status estimation</title><p>Total plasma antioxidant status (TAS) in plasma was estimated by the ferric reducing antioxidant assay.[<xref ref-type="bibr" rid="ref17">17</xref>] The method is based on the principle that at low pH, reduction of ferric&#x02013;tripyridyltriazinie (Fe III&#x02013;TPTZ) complex to the ferrous form, which has an intense blue color can be monitored by measuring the absorbance. The absorbance is directly related to the combined or &#x0201c;total&#x0201d; reducing power of the electron-donating antioxidants present in the reaction mixture.</p></sec><sec id="sec2-3"><title>Statistical analysis</title><p>Data were analyzed using the statistical program SPSS for Windows, version 13 (SPSS, USA). Results are given as mean &#x000b1; standard deviation (SD). Independent Student's <italic>t</italic> test was used to determine the statistically significant difference between cases and controls. Paired Student's t test was used for comparison of the parameters studied before and after treatment. <italic>P</italic> values less than 0.05 were considered statistically significant.</p></sec></sec><sec sec-type="results" id="sec1-2"><title>RESULTS</title><p>Hematologic and biochemical parameters in <italic>H. pylori</italic>-infected anemic group are given in <xref ref-type="table" rid="T1">Table 1</xref>. Levels of PCOs were significantly increased in the test group than the healthy age-matched controls (<italic>P</italic> &#x0003c; 0.001). Total antioxidant status was significantly lower in the cases than in the controls (<italic>P</italic> &#x0003c; 0.001). The baseline levels of hematologic and biochemical parameters studied were comparable between the 2 groups [<xref ref-type="table" rid="T2">Table 2</xref>]. Hemoglobin, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), reticulocyte count, serum iron, and ferritin levels were significantly reduced in <italic>H. pylori</italic>-infected patients when compared with controls.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Comparison of hematologic and biochemical parameters in anemic <italic>Helicobacter pylori</italic>-infected patients and controls</p></caption><graphic xlink:href="SJG-18-252-g001"/></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Changes in protein carbonyls and total antioxidant status in test groups after treatment</p></caption><graphic xlink:href="SJG-18-252-g002"/></table-wrap><sec id="sec2-4"><title>Response to therapy</title><p>The mean increase in hemoglobin levels (2.97 vs 0.71 g/L), serum iron levels (47.8 vs 16.3 mg/dL), and ferritin levels (78 vs 26.6 ng/mL) were more marked in Group I than in Group II. Patients in Group I had a greater decrease in mean PCOs (1.24 nmol/mg protein) after 1 month of treatment than those in Group II (0.612 nmol/mg protein). Increase in the mean TAS (375 nmol/L) after treatment was also higher in Group I in comparison with Group II (129 nmol/L). After therapy, the mean PCO levels were significantly lower and TAS higher when compared with the basal levels in Group I and no significant difference was found in Group II [<xref ref-type="table" rid="T2">Table 2</xref>]. After treatment, the levels of PCO and TAS improved and no significant difference was found in Group I when compared with controls, whereas significant difference was seen in Group II.</p></sec></sec><sec sec-type="discussion" id="sec1-3"><title>DISCUSSION</title><p>Free radical generation is an important phenomenon that is known to contribute in a great variety of deleterious reactions in the aerobic cells.[<xref ref-type="bibr" rid="ref18">18</xref><xref ref-type="bibr" rid="ref19">19</xref>] It is now generally accepted that oxidative stress plays an important role in the pathogenesis of various forms of tissue injuries.[<xref ref-type="bibr" rid="ref20">20</xref>&#x02013;<xref ref-type="bibr" rid="ref23">23</xref>] Oxidative damage caused by free radicals that are generated against the <italic>H. pylori</italic> plays a crucial role in the pathogenesis of gastric cancer.[<xref ref-type="bibr" rid="ref24">24</xref><xref ref-type="bibr" rid="ref25">25</xref>] Increased amounts of oxidative markers of lipid injury have been found in patients with <italic>H. pylori</italic> infection. [<xref ref-type="bibr" rid="ref11">11</xref><xref ref-type="bibr" rid="ref12">12</xref>] However, to the best of our knowledge, this is the first study attempted to elucidate whether there is any change in the protein carbonylation and total antioxidant status in anemic <italic>H. pylori</italic>-infected patients and effects of treatment on them.</p><p>Protein carbonylation is one of the reactions set into motion as a consequence of the formation of these radicals in cells and tissues.[<xref ref-type="bibr" rid="ref26">26</xref>] PCOs are formed early and circulate in the blood for longer periods, compared with the other parameters of oxidative stress, such as glutathione disulfide and MDA.[<xref ref-type="bibr" rid="ref15">15</xref>] Quantification of PCOs could be used to measure the extent of oxidative modification. Our results indicate increased PCOs in <italic>H. pylori</italic>-infected anemic patients. Previous reports have also reported high levels of lipid peroxidation in patients infected with <italic>H. pylori</italic>.[<xref ref-type="bibr" rid="ref11">11</xref><xref ref-type="bibr" rid="ref12">12</xref>]</p><p>There was a significant decrease in the PCO levels in <italic>H. pylori</italic>-infected patients after 1 month of treatment with both ferrous sulfate and anti-<italic>H. pylori</italic> therapy. Previous reports have indicated that the levels of lipid peroxides decrease significantly after treatment of <italic>H. pylori</italic> infection.[<xref ref-type="bibr" rid="ref11">11</xref><xref ref-type="bibr" rid="ref12">12</xref>] Similarly, in iron deficiency anemia it has been found that supplementation with iron reduces the levels of MDA.[<xref ref-type="bibr" rid="ref14">14</xref>] In this study, there was no significant decrease in PCO levels in the test group treated with only oral iron. This clearly shows that in <italic>H. pylori</italic>-infected individuals, anti-<italic>H. pylori</italic> therapy is needed along with iron for early reduction of oxidative stress. This finding also reveals that the contribution of oxidative stress by <italic>H. pylori</italic> infection might be greater than anemia per se in anemic <italic>H. pylori</italic> infection. Also, except for the reticulocyte count, there was no significant improvement in hemoglobin, serum iron, ferritin levels, and hematologic parameters in Group II, whereas Group I showed good improvement. These results support the conclusion that anti-<italic>H. pylori</italic> treatment is needed for early correction of iron deficiency anemia in these patients. Both improvement in the iron absorption and reduction of oxidative stress with anti-<italic>H. pylori</italic> therapy might have contributed for early correction of anemia in these patients.</p><p>A number of researches have been carried out to study the alterations in vitamin C levels in both gastric juice and plasma of patients with <italic>H. pylori</italic> infection. A significant decrease in the levels of vitamin C has been reported and successful eradication of <italic>H. pylori</italic> infection restored the gastric juice and plasma levels of ascorbic acid.[<xref ref-type="bibr" rid="ref11">11</xref><xref ref-type="bibr" rid="ref27">27</xref>&#x02013;<xref ref-type="bibr" rid="ref29">29</xref>]</p><p>Our study indicates a significant reduction in the total antioxidant status in <italic>H. pylori</italic>-infected patients. The mean rise in total antioxidant status of the blood samples from <italic>H. pylori</italic>-infected subjects was significant after <italic>H. pylori</italic> treatment. Eradication of <italic>H. pylori</italic> thus appears to inhibit the activation of circulating mononuclear cells in patients. Therefore, oxidative stress not only in the gastric mucosa but also in the circulation of patients with <italic>H. pylori</italic> infection is significantly decreased after eradication of this pathogen.</p><p>We conclude that increased levels of PCOs and decreased total antioxidant status were found in anemic <italic>H. pylori</italic>-infected patients. Also this study indicates that treatment for both anemia and <italic>H. pylori</italic> infections is required for decreasing the oxidative stress, which synergistically brings about an appropriate correction of anemia soon in these patients.</p></sec></body><back><ack><title>ACKNOWLEDGMENT</title><p>The authors thank Dr. Archana Nimesh and Dr. Selvaraj Nambiar for manuscript editing.</p></ack><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Nil</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cover</surname><given-names>TL</given-names></name><name><surname>Blaser</surname><given-names>MJ</given-names></name></person-group><article-title><italic>Helicobacter pylori</italic> and gastroduodenal disease</article-title><source>Annu Rev Med</source><year>1992</year><volume>43</volume><fpage>135</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">1580578</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodman</surname><given-names>KJ</given-names></name><name><surname>Cockburn</surname><given-names>M</given-names></name></person-group><article-title>The role of epidemiology in understanding the health effects of <italic>Helicobacter pylori</italic></article-title><source>Epidemiology</source><year>2001</year><volume>12</volume><fpage>266</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">11246592</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malaty</surname><given-names>HM</given-names></name><name><surname>Graham</surname><given-names>DY</given-names></name></person-group><article-title>Importance of childhood socioeconomic status on the current prevalence of <italic>Helicobacter pylori</italic> infection</article-title><source>Gut</source><year>1994</year><volume>35</volume><fpage>742</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">8020796</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berg</surname><given-names>G</given-names></name><name><surname>Bode</surname><given-names>G</given-names></name><name><surname>Blettner</surname><given-names>M</given-names></name><name><surname>Boeing</surname><given-names>H</given-names></name><name><surname>Brenner</surname><given-names>H</given-names></name></person-group><article-title><italic>Helicobacter pylori</italic> infection and serum ferritin: A population-based study among 1806 adults in Germany</article-title><source>Am J Gastroenterol</source><year>2001</year><volume>96</volume><fpage>1014</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11316140</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milman</surname><given-names>N</given-names></name><name><surname>Rosenstock</surname><given-names>S</given-names></name><name><surname>Andersen</surname><given-names>L</given-names></name><name><surname>Jorgensen</surname><given-names>T</given-names></name><name><surname>Bonnevie</surname><given-names>O</given-names></name></person-group><article-title>Serum ferritin, hemoglobin, and <italic>Helicobacter pylori</italic> infection: A sero-epidemiologic survey comprising 2794 Danish adults</article-title><source>Gastroenterology</source><year>1998</year><volume>115</volume><fpage>268</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">9679031</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marignani</surname><given-names>M</given-names></name><name><surname>Angeletti</surname><given-names>S</given-names></name><name><surname>Bordi</surname><given-names>C</given-names></name><name><surname>Malagnino</surname><given-names>F</given-names></name><name><surname>Mancino</surname><given-names>C</given-names></name><name><surname>Delle Fave</surname><given-names>G</given-names></name><etal/></person-group><article-title>Reversal of long-standing iron deficiency anemia after eradication of <italic>Helicobacter pylori</italic> infection</article-title><source>Scand J Gastroenterol</source><year>1997</year><volume>32</volume><fpage>617</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">9200297</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choe</surname><given-names>YH</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Son</surname><given-names>BK</given-names></name><name><surname>Lee</surname><given-names>DH</given-names></name><name><surname>Hong</surname><given-names>YC</given-names></name><name><surname>Pai</surname><given-names>SH</given-names></name></person-group><article-title>Randomized placebo-controlled trial of <italic>Helicobacter pylori</italic> eradication for iron-deficiency anemia in preadolescent children and adolescents</article-title><source>Helicobacter</source><year>1999</year><volume>4</volume><fpage>135</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">10382128</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rantelin</surname><given-names>H</given-names></name><name><surname>Blonberg</surname><given-names>B</given-names></name><name><surname>Fredlund</surname><given-names>H</given-names></name><name><surname>Jarrool</surname><given-names>G</given-names></name><name><surname>Danialion</surname><given-names>D</given-names></name></person-group><article-title>Incidence of <italic>Helicobacter pylori</italic> strains activating neutrophils in patients with peptic ulcer disease</article-title><source>Gut</source><year>1993</year><volume>34</volume><fpage>599</fpage><lpage>603</lpage><pub-id pub-id-type="pmid">8504958</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Troll</surname><given-names>W</given-names></name><name><surname>Wiesner</surname><given-names>R</given-names></name></person-group><article-title>The role of oxygen radicals as a possible mechanism of tumor promotion</article-title><source>Annu Rev Pharmacol Toxicol</source><year>1985</year><volume>25</volume><fpage>509</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">3890710</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imlay</surname><given-names>JA</given-names></name><name><surname>Linn</surname><given-names>S</given-names></name></person-group><article-title>DNA damage and oxygen radical toxicity</article-title><source>Science</source><year>1988</year><volume>240</volume><fpage>1302</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">3287616</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waring</surname><given-names>AJ</given-names></name><name><surname>Drake</surname><given-names>IM</given-names></name><name><surname>Schorah</surname><given-names>CJ</given-names></name><name><surname>White</surname><given-names>KL</given-names></name><name><surname>Lynch</surname><given-names>DA</given-names></name><name><surname>Ason</surname><given-names>AT</given-names></name><etal/></person-group><article-title>Ascorbic acid and total vitamin C concentrations in plasma, gastric juice and gastrointestinal mucosa: Effects of gastritis and oral supplementation</article-title><source>Gut</source><year>1996</year><volume>38</volume><fpage>171</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">8801192</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>MA</given-names></name><name><surname>Kim</surname><given-names>BS</given-names></name><name><surname>Yu</surname><given-names>R</given-names></name></person-group><article-title>Serum antioxidative vitamin levels and lipid peroxidation in gastric carcinoma patients</article-title><source>Cancer Lett</source><year>1999</year><volume>136</volume><fpage>89</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">10211945</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vijayan</surname><given-names>G</given-names></name><name><surname>Sundaram</surname><given-names>RC</given-names></name><name><surname>Bobby</surname><given-names>Z</given-names></name><name><surname>Hamide</surname><given-names>A</given-names></name><name><surname>Selvaraj</surname><given-names>N</given-names></name><name><surname>Dasse</surname><given-names>NR</given-names></name></person-group><article-title>Increased plasma malondialdehyde and fructosamine in anemic <italic>H pylori</italic> infected patients: Effect of treatment</article-title><source>World J Gastroenterol</source><year>2007</year><volume>13</volume><fpage>796</fpage><lpage>800</lpage><pub-id pub-id-type="pmid">17278206</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurtoglu</surname><given-names>E</given-names></name><name><surname>Ugur</surname><given-names>A</given-names></name><name><surname>Baltaci</surname><given-names>AK</given-names></name><name><surname>Undar</surname><given-names>L</given-names></name></person-group><article-title>Effect of iron supplementation on oxidative stress and antioxidant status in iron-deficiency anemia</article-title><source>Biol Trace Elem Res</source><year>2003</year><volume>96</volume><fpage>117</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">14716090</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sundaram</surname><given-names>RC</given-names></name><name><surname>Selvaraj</surname><given-names>N</given-names></name><name><surname>Vijayan</surname><given-names>G</given-names></name><name><surname>Bobby</surname><given-names>Z</given-names></name><name><surname>Hamide</surname><given-names>A</given-names></name><name><surname>Rattina Dasse</surname><given-names>N</given-names></name></person-group><article-title>Increased plasma malondialdehyde and fructosamine in iron deficiency anemia: Effect of treatment</article-title><source>Biomed Pharmacother</source><year>2007</year><volume>61</volume><fpage>682</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">17698317</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Zwart</surname><given-names>LL</given-names></name><name><surname>Meerman</surname><given-names>JH</given-names></name><name><surname>Commandeur</surname><given-names>JN</given-names></name><name><surname>Vermeulen</surname><given-names>NP</given-names></name></person-group><article-title>Biomarkers of free radical damage applications in experimental animals and in humans</article-title><source>Free Radic Biol Med</source><year>1999</year><volume>26</volume><fpage>202</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">9890655</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname><given-names>RL</given-names></name><name><surname>Williams</surname><given-names>JA</given-names></name><name><surname>Stadtman</surname><given-names>BR</given-names></name><name><surname>Shacter</surname><given-names>E</given-names></name></person-group><article-title>Carbonyl assays for determination of oxidatively modified proteins</article-title><source>Methods Enzymol</source><year>1994</year><volume>233</volume><fpage>346</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">8015469</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohen</surname><given-names>R</given-names></name><name><surname>Nyska</surname><given-names>A</given-names></name></person-group><article-title>Oxidation of biological systems: Oxidative stress phenomena, antioxidants, redox reactions and methods for their quantification</article-title><source>Toxicol Pathol</source><year>2002</year><volume>30</volume><fpage>620</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">12512863</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selvaraj</surname><given-names>N</given-names></name><name><surname>Bobby</surname><given-names>Z</given-names></name><name><surname>Sridhar</surname><given-names>MG</given-names></name></person-group><article-title>Oxidative stress: Does it play a role in the genesis of early glycated proteins?</article-title><source>Med Hypotheses</source><year>2008</year><volume>70</volume><fpage>265</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17693039</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selvaraj</surname><given-names>N</given-names></name><name><surname>Bobby</surname><given-names>Z</given-names></name><name><surname>Sridhar</surname><given-names>MG</given-names></name></person-group><article-title>Increased glycation of hemoglobin in chronic renal failure; [corrected] potential role in oxidative stress</article-title><source>Arch Med Res</source><year>2008</year><volume>39</volume><fpage>277</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">18279699</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soundravally</surname><given-names>R</given-names></name><name><surname>Sankar</surname><given-names>P</given-names></name><name><surname>Hoti</surname><given-names>SL</given-names></name><name><surname>Selvaraj</surname><given-names>N</given-names></name><name><surname>Bobby</surname><given-names>Z</given-names></name><name><surname>Sridhar</surname><given-names>MG</given-names></name></person-group><article-title>Oxidative stress induced changes in plasma protein can be a predictor of imminent severe dengue infection</article-title><source>Acta Trop</source><year>2008</year><volume>106</volume><fpage>156</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">18420173</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sathiyapriya</surname><given-names>V</given-names></name><name><surname>Selvaraj</surname><given-names>N</given-names></name><name><surname>Nandeesha</surname><given-names>H</given-names></name><name><surname>Bobby</surname><given-names>Z</given-names></name><name><surname>Agrawal</surname><given-names>A</given-names></name><name><surname>Pavithran</surname><given-names>P</given-names></name></person-group><article-title>Enhanced glycation of hemoglobin and plasma proteins is associated with increased lipid peroxide levels in non-diabetic hypertensive subjects</article-title><source>Arch Med Res</source><year>2007</year><volume>38</volume><fpage>822</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">17923261</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nambiar</surname><given-names>S</given-names></name><name><surname>Viswanathan</surname><given-names>S</given-names></name><name><surname>Zachariah</surname><given-names>B</given-names></name><name><surname>Hanumanthappa</surname><given-names>N</given-names></name><name><surname>Magadi</surname><given-names>SG</given-names></name></person-group><article-title>Oxidative stress in prehypertension: Rationale for antioxidant clinical trials</article-title><source>Angiology</source><year>2009</year><volume>60</volume><fpage>221</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">18796443</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hando</surname><given-names>O</given-names></name><name><surname>Naito</surname><given-names>Y</given-names></name><name><surname>Yoshikawa</surname><given-names>T</given-names></name></person-group><article-title><italic>Helicobacter pylori</italic>; a ROS-inducing bacterial species in the stomach</article-title><source>Inflamm Res</source><year>2010</year><volume>59</volume><fpage>997</fpage><lpage>1003</lpage><pub-id pub-id-type="pmid">20820854</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Handa</surname><given-names>O</given-names></name><name><surname>Naito</surname><given-names>Y</given-names></name><name><surname>Yoshikawa</surname><given-names>T</given-names></name></person-group><article-title>Redox biology and gastric carcinogenesis: The role of <italic>Helicobacter pylori</italic></article-title><source>Redox Rep</source><year>2011</year><volume>16</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">21605492</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berlett</surname><given-names>BS</given-names></name><name><surname>Stadtman</surname><given-names>ER</given-names></name></person-group><article-title>Protein oxidation in aging, disease, and oxidative stress</article-title><source>J Biol Chem</source><year>1997</year><volume>272</volume><fpage>20313</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">9252331</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farinati</surname><given-names>F</given-names></name><name><surname>Della Libera</surname><given-names>G</given-names></name><name><surname>Cardin</surname><given-names>R</given-names></name><name><surname>Molari</surname><given-names>A</given-names></name><name><surname>Pelabani</surname><given-names>M</given-names></name><name><surname>Rugge</surname><given-names>M</given-names></name><etal/></person-group><article-title>Gastric antioxidant, nitrites and mucosal lipoperoxidation in chronic gastritis and <italic>Helicobacter pylori</italic> infection</article-title><source>J Clin Gastroenterol</source><year>1996</year><volume>22</volume><fpage>275</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">8771422</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gotz</surname><given-names>JM</given-names></name><name><surname>Thio</surname><given-names>JL</given-names></name><name><surname>Verspaget</surname><given-names>HW</given-names></name><name><surname>Offerhaus</surname><given-names>GJ</given-names></name><name><surname>Biemond</surname><given-names>I</given-names></name><name><surname>Lamers</surname><given-names>CB</given-names></name><etal/></person-group><article-title>Treatment of Helicobacter pylori infection favorably affects gastric mucosal superoxide dismutases</article-title><source>Gut</source><year>1997</year><volume>40</volume><fpage>591</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">9203935</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz</surname><given-names>B</given-names></name><name><surname>Rood</surname><given-names>JC</given-names></name><name><surname>Fontham</surname><given-names>ET</given-names></name><name><surname>Malcom</surname><given-names>GT</given-names></name><name><surname>Hunter</surname><given-names>FM</given-names></name><name><surname>Sobhan</surname><given-names>M</given-names></name><etal/></person-group><article-title>Vitamin C concentration in gastric juice before and after anti-<italic>Helicobacter pylori</italic> treatment</article-title><source>Am J Gastroenterol</source><year>1994</year><volume>89</volume><fpage>533</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">8147356</pub-id></element-citation></ref></ref-list></back></article>